Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody

Luo, Wenjie, Liu, Wencheng, Hu, Xiaoyan, Hanna, Mary, Caravaca, April, Paul, Steven M.·2015·Scientific Reports
DOI 10.1038/srep11161

Cited by (241)

Items 101–200 of 241

  1. Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases
    Michael Poppell, Grace Hammel, Yi Ren · 2023 · International Journal of Molecular Sciences
  2. Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors
    Gabriel Gustafsson, Fredrik Eriksson, Christer Möller, Tomás Lopes da Fonseca, Tiago F. Outeiro, Lars Lannfelt, Joakim J. E. Bergström, Martin Ingelsson · 2016 · Cellular and Molecular Neurobiology
  3. The potential role of glial cells in driving the prion-like transcellular propagation of tau in tauopathies
    Zein Amro, Andrea J. Yool, Lyndsey E. Collins‐Praino · 2021 · Brain Behavior & Immunity - Health
  4. Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease
    Shwetha Nanjundaiah, Hariharakrishnan Chidambaram, Madhura Chandrashekar, Subashchandrabose Chinnathambi · 2020 · Cellular and Molecular Neurobiology
  5. A new generation of AD biomarkers: 2019 to 2021
    Jade I. Hawksworth, Esperanza Fernández, Kris Gevaert · 2022 · Ageing Research Reviews
  6. Microglial phagocytosis in Alzheimer disease
    Brown, Guy C., St George-Hyslop, Peter, Paolicelli, Rosa C., Lemke, Greg · 2026 · Nature Reviews Neurology
  7. Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders
    Aurélie de Rus Jacquet, Hélèna L. Denis, Francesca Cicchetti, Melanie Alpaugh · 2021 · Molecular Psychiatry
  8. Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming
    Dayuan Wang, Xiao Qin Gu, Xinyi Ma, Jun Chen, Qizhi Zhang, Zhihua Yu, Juan Li, Hu Meng, Xiaofang Tan, Yuyun Tang et al. · 2022 · Acta Pharmaceutica Sinica B
  9. Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
    Monika Žilková, Anna Nölle, Branislav Kováčech, Eva Kontseková, Petronela Weisová, Peter Filipčík, Rostislav Škrabana, Michal Prčina, Tomáš Hromádka, Ondrej Cehlár et al. · 2020 · Acta Neuropathologica Communications
  10. Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies
    Sonja Fixemer, Corrado Ameli, Gaël Paul Hammer, Luis Salamanca, Oihane Uriarte Huarte, Chantal Schwartz, Jean‐Jacques Gérardy, Naguib Mechawar, Alexander Skupin, Michel Guy André Mittelbronn et al. · 2022 · Acta Neuropathologica Communications
  11. Single domain antibodies targeting pathological tau protein: Influence of four IgG subclasses on efficacy and toxicity
    Erin E. Congdon, Ruimin Pan, Yixiang Jiang, Leslie A. Sandusky‐Beltran, Andie Dodge, Yan Lin, Mengyu Liu, Min‐Hao Kuo, Xiang‐Peng Kong, Einar M. Sigurdsson · 2022 · EBioMedicine
  12. How brain ‘cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer's disease
    Junjun Ni, Zhen Xie, Zhenzhen Quan, Jie Meng, Hong Qing · 2023 · Glia
  13. Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
    Eckenweber, Florian, Medina-Luque, Jose, Blume, Tanja, Sacher, Christian, Biechele, Gloria, Wind, Karin, Deussing, Maximilian, Briel, Nils, Lindner, Simon, Boening, Guido et al. · 2020 · Journal of Neuroinflammation
  14. Evidence of the Cellular Senescence Stress Response in Mitotically Active Brain Cells—Implications for Cancer and Neurodegeneration
    Gregory James Gillispie, Eric Sah, Sudarshan Krishnamurthy, Mohamed Y. Ahmidouch, Bin Zhang, Miranda E. Orr · 2021 · Life
  15. 3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic Mice
    Hongjun Fu, S. Abid Hussaini, Susanne Wegmann, Caterina P. Profaci, Jacob D. Daniels, Mathieu Herman, Sheina Emrani, Helen Y. Figueroa, Bradley T. Hyman, Peter Davies et al. · 2016 · PLoS ONE
  16. Targeted protein degradation using intracellular antibodies and its application to neurodegenerative disease
    Jonathan Benn, Aamir S. Mukadam, William A. McEwan · 2021 · Seminars in Cell and Developmental Biology
  17. Proposed mechanisms of tau: relationships to traumatic brain injury, Alzheimer’s disease, and epilepsy
    Samantha P. Martin, Beth A. Leeman-Markowski · 2024 · Frontiers in Neurology
  18. The age-related microglial transformation in Alzheimer's disease pathogenesis
    Chunxu Yuan, Ailikemu Aierken, Zhen Xie, Nuomin Li, Juan Zhao, Hong Qing · 2020 · Neurobiology of Aging
  19. Friend or foe: role of pathological tau in neuronal death
    Moxin Wu, Zhiying Chen, Min Hua Jiang, Bing Bao, Dongling Li, Xiaoping Yin, Xueren Wang, Dan Liu, Ling‐Qiang Zhu · 2023 · Molecular Psychiatry
  20. Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma
    Michael W. Ronellenfitsch, Pia Susann Zeiner, Michel Guy André Mittelbronn, Hans Urban, Torsten Pietsch, Dirk Reuter, Christian Senft, Joachim Peter Steinbach, Manfred Westphal, Patrick N. Harter · 2018 · Acta Neuropathologica Communications
  21. Distinct Microglial Responses in Two Transgenic Murine Models of TAU Pathology
    Carmen Romero‐Molina, Victoria Navarro, Raquel Maria Sanchez-Varo, Sebastián Jiménez, Juan José Fernandez-Valenzuela, Maria Virtudes Sanchez-Mico, Clara Muñoz‐Castro, Antonia Gutiérrez, Javier Vitórica, Marisa Vizuete · 2018 · Frontiers in Cellular Neuroscience
  22. Ultrasound-mediated delivery of novel tau-specific monoclonal antibody enhances brain uptake but not therapeutic efficacy
    Rinie Bajracharya, Esteban Cruz, Jürgen Götz, Rebecca M. Nisbet · 2022 · Journal of Controlled Release
  23. Neurotoxic Microglial Activation via IFNγ‐Induced Nrf2 Reduction Exacerbating Alzheimer's Disease
    You Jung Kang, Seung Jae Hyeon, Amanda McQuade, Jiwoon Lim, Seung Hyun Baek, Yen Ngoc Diep, Khanh Do, Yeji Jeon, Dong‐Gyu Jo, Changjoon Justin Lee et al. · 2024 · Advanced Science
  24. Delivery of Intravenously Administered Antibodies Targeting Alzheimer’s Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis
    Toshihiko Tashima · 2022 · Pharmaceutics
  25. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer’s disease patients and AppNL−F/NL−F mice
    Cristina Nuñez‐Diaz, Emelie Andersson, Nina Schultz, Dovilė Pocevičiūtė, Oskar Hansson, The Netherlands Brain Bank, K. Peter R. Nilsson, Malin Wennström · 2024 · Alzheimer s Research & Therapy
  26. G-protein coupled receptors regulates Tauopathy in neurodegeneration
    Subashchandrabose Chinnathambi, Hariharakrishnan Chidambaram · 2024 · Advances in protein chemistry and structural biology
  27. p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function
    Juan Ramón Perea, Marta Bolós, Raquel Cuadros, Esther García, Vega García‐Escudero, Félix Hernández, Róisín M. McManus, Michael Thomas Heneka, Jesús Ávila · 2022 · Molecular Neurobiology
  28. Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma
    Rayane Hedna, Hervé Kovacic, Alessandra Pagano, Vincent Peyrot, Maxime Robin, François Devred, Gilles Breuzard · 2022 · Cancers
  29. Microglia internalize tau monomers and fibrils using distinct receptors but similar mechanisms
    Kristian F. Falkon, Liliana Danford, Eduardo Gutierrez Kuri, Paulina Esquinca‐Moreno, Yaren L. Peña Señeriz, Sabrina A. Smith, Jessica L. Wickline, Ariel Louwrier, Jacob Alec McPhail, Naomi L. Sayre et al. · 2024 · Alzheimer s & Dementia
  30. P2X7R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes
    Paula Beltran-Lobo, Martina M. Hughes, C. Troakes, C. L. Croft, H. Rupawala, Daniel Jutzi, M. Ruepp, Maria Jimenez-Sanchez, M. Perkinton, Michael Kassiou et al. · 2023 · Brain, behavior, and immunity
  31. Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice
    Tuancheng Feng, Huan Du, Cha Yang, Ya Wang, Fenghua Hu · 2024 · Acta Neuropathologica
  32. Molecular Regulation Mechanism of Microglial Autophagy in the Pathology of Alzheimer's Disease
    Pei Ou-Yang, Zhiyu Cai, Zhong-Hao Zhang · 2023 · Aging and Disease
  33. Osteopontin: A novel marker of pre‐symptomatic sporadic Alzheimer's disease
    Marc James Quesnel, Anne Labonté, Cynthia Picard, Daniel C. Bowie, Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm, Sylvia Villeneuve, Judes Poirier, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
  34. TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo
    Lee-Gosselin, Audrey, Jury-Garfe, Nur, You, Yanwen, Dabin, Luke, Soni, Disha, Dutta, Sayan, Rochet, Jean-Christophe, Kim, Jungsu, Oblak, Adrian L., Lasagna-Reeves, Cristian A. · 2023 · Cells
  35. Landscape of brain myeloid cell transcriptome along the spatiotemporal progression of Alzheimer’s disease reveals distinct sequential responses to Aβ and tau
    Astrid Wachter, Maya E. Woodbury, Sylvia Lombardo, Aicha Abdourahman, Carolin Wuest, Emily J. McGlame, Timothy Pastika, Joseph A. Tamm, Nandini Romanul, Kiran Yanamandra et al. · 2024 · Acta Neuropathologica
  36. Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model
    Dov B. Shamir, Yan Deng, Qian Wu, Swananda Modak, Erin E. Congdon, Einar M. Sigurdsson · 2020 · Frontiers in Neurology
  37. PACAP27 mitigates an age‐dependent hippocampal vulnerability to PGJ2‐induced spatial learning deficits and neuroinflammation in mice
    Jorge A. Avila, Magdalena Kiprowska, Teneka L Jean-Louis, Patricia Rockwell, Maria E. Figueiredo‐Pereira, Peter A. Serrano · 2019 · Brain and Behavior
  38. Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner
    Bittar, Alice, Al-Lahham, Rabab, Bhatt, Nemil, Moore, Kenya, Montalbano, Mauro, Jerez, Cynthia, Fung, Leiana, McAllen, Salome, Ellsworth, Anna, Kayed, Rakez · 2022 · Journal of Alzheimer's Disease
  39. Implications for microglial sex differences in tau-related neurodegenerative diseases
    Yasmine V. Doust, Anna Elizabeth King, Jenna M. Ziebell · 2021 · Neurobiology of Aging
  40. Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice
    Rinie Bajracharya, David Brici, Liviu‐Gabriel Bodea, Phillip W. Janowicz, Jürgen Götz, Rebecca M. Nisbet · 2021 · Acta Neuropathologica Communications
  41. Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study
    Jesper Skov Neergaard, Katrine Dragsbæk, Claus Christiansen, M.A. Karsdal, Susanne Brix, Kim Henriksen · 2018 · PLoS ONE
  42. p38 activation occurs mainly in microglia in the P301S Tauopathy mouse model
    Juan Ramón Perea, Esther García, Laura Vallés‐Saiz, Raquel Cuadros, Félix Hernández, Marta Bolós, Jesús Ávila · 2022 · Scientific Reports
  43. Key brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease
    Joana Saavedra, Mariana Nascimento, Márcia A. Liz, Isabel Cardoso · 2022 · Frontiers in Cell and Developmental Biology
  44. Neurodegeneration Enhances the Development of Arthritis
    Stefanie C. Lang, Ulrike Harre, Pavitra Purohit, Katharina Dietel, Deborah Kienhöfer, Jonas Hahn, Wolfgang Baum, Martin Herrmann i, Georg Andreas Schett, Dirk Mielenz · 2017 · The Journal of Immunology
  45. The Influence of the Gut Microbiota on Alzheimer's Disease: A Narrative Review
    Jun-Ting Yin, Xiaowei Xu, Chen-Yang Jin, Xiaoying Yuan, Xugang Wang · 2023 · Journal of Integrative Neuroscience
  46. Microglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis
    Md Sadique Hussain, Yumna Khan, Rabab Fatima, Mudasir Maqbool, Prasanna Srinivasan Ramalingam, Mohammad Gayoor Khan, Ajay Singh Bisht · 2025 · Current Alzheimer Research
  47. Refining the interactions between microglia and astrocytes in Alzheimer’s disease pathology
    Jiangmin Chen, Shuyu Xu, Li Wang, Xinyuan Liu, Guangya Liu, Qian Tan, Weixian Li, Shuai Zhang, Yanjun Du · 2025 · Neuroscience
  48. Absence of microglia or presence of peripherally‐derived macrophages does not affect tau pathology in young or old hTau mice
    Keying Zhu, Melanie Pieber, Jinming Han, Klas Blomgren, Xing‐Mei Zhang, Robert Adam Harris, Harald Lund · 2020 · Glia
  49. Should We Open Fire on Microglia? Depletion Models as Tools to Elucidate Microglial Role in Health and Alzheimer’s Disease
    Carmen Romero‐Molina, Victoria Navarro, Sebastián Jiménez, Clara Muñoz‐Castro, Maria Virtudes Sanchez-Mico, Antonia Gutiérrez, Javier Vitórica, Marisa Vizuete · 2021 · International Journal of Molecular Sciences
  50. Crry silencing alleviates Alzheimer’s disease injury by regulating neuroinflammatory cytokines and the complement system
    Xi‐Chen Zhu, Tao Ma, Lu Liu, Wen-Zhuo Dai · 2021 · Neural Regeneration Research
  51. Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia
    Chang Jae Yoo, Youngtae Choi, Eugene Bok, Yuxi Lin, Mookyung Cheon, Young‐Ho Lee, Jaekwang Kim · 2024 · FEBS Journal
  52. Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches
    Younes Yassaghi, Yasaman Nazerian, Mobina Ghasemi, Amirhossein Nazerian, Fatemeh Sayehmiri, George L. Perry, Hamid Gholami Pourbadie · 2024 · Journal of Cellular and Molecular Medicine
  53. Internalization of extracellular Tau oligomers in Alzheimer’s disease
    Subashchandrabose Chinnathambi, Nagaraj Rangappa, Madhura Chandrashekar · 2025 · Advances in clinical chemistry
  54. Immunization targeting diseased proteins in synucleinopathy and tauopathy: insights from clinical trials
    Xiaoni Zhan, Gehua Wen, Xu Wu, Jiayi Li · 2025 · Translational Neurodegeneration
  55. Matrix metalloproteinase-degraded type I collagen is associated with APOE/TOMM40 variants and preclinical dementia
    Man‐Hung Eric Tang, Joseph Blair, Cecilie Liv Bager, Anne‐Christine Bay‐Jensen, Kim Henriksen, Claus Christiansen, M.A. Karsdal · 2020 · Neurology Genetics
  56. Extracellular tau clearance is governed by its aggregation state and independent of microglial activation by LPS and IFN-γ
    Andrew Shultz, Anna Vincze, Todd T. Yau, Emma L. Poirier, Hannah Demanche, Jennifer N. Rauch · 2025 · Neurobiology of Disease
  57. The mitochondrial translocator protein (TSPO) in Alzheimer's disease: Therapeutic and immunomodulatory functions
    Lauren Hermes Fairley, Kei Onn Lai, Amandine Grimm, Anne Eckert, Anna M. Barron · 2024 · Biochimie
  58. Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives
    Margrethe A. Olesen, Francisca Villavicencio-Tejo, Victor Cuevas-Espinoza, Rodrigo A. Quintanilla · 2024 · Ageing Research Reviews
  59. Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases
    Yeseong Choi, Won‐Suk Chung · 2025 · Molecular Neurodegeneration
  60. Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
    Neha Basheer, Luc Buée, Jean‐Pierre Brion, Tomáš Smolek, Muhammad Khalid Muhammadi, Jozef Hritz, Tomáš Hromádka, Ilse Dewachter, Susanne Wegmann, Isabelle Landrieu et al. · 2024 · Acta Neuropathologica Communications
  61. Connectome-based biophysics models of Alzheimer’s disease diagnosis and prognosis
    Justin Torok, Chaitali Anand, Parul Verma, Ashish Raj · 2022 · Translational research
  62. Enhancing CNS mitophagy: drug development and disease-relevant models
    Krishayant S. Dhar, Brendan Townsend, Andrew P. Montgomery, Jonathan J. Danon, Julia K. Pagan, Michael Kassiou · 2024 · Trends in Pharmacological Sciences
  63. Roles of Microglia in AD Pathology
    Rong Gao, Hongrong Wu, Qingqi Li, Jianfeng Zhao · 2023 · Current Alzheimer Research
  64. Therapeutic approaches to microglial dysfunction in Alzheimer's disease: Enhancing phagocytosis and metabolic regulation
    Waleed Hassan Almalki, Salem Salman Almujri · 2024 · Pathology - Research and Practice
  65. Tau and β-Amyloid Relevant Pathology as a Central Therapeutic Target in Alzheimer’s Disease
    Lidia Strużyńska, Kamil Adamiak, Marta Sidoryk‐Wȩgrzynowicz · 2026 · Biomolecules
  66. Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
    Andrea C. Klaver, Mary P. Coffey, David Alan Bennett, David A. Loeffler · 2017 · Translational Neurodegeneration
  67. Intramuscular injection of vectorized-scFvMC1 reduces pathological tau in two different tau transgenic models
    Francesca Vitale, Jasmin Ortolan, Bruce T. Volpe, Philippe Marambaud, Luca Giliberto, Cristina d’Abramo · 2020 · Acta Neuropathologica Communications
  68. Diverse influences on tau aggregation and implications for disease progression
    Meaghan Van Alstyne, James Pratt, Roy Parker · 2025 · Genes & Development
  69. DAP12 deletion reduces neuronal SLIT2 and demyelination and enhances brain resilience in female tauopathy mice
    Hao Chen, Li Fan, Qi Guo, Man Ying Wong, Jingjie Zhu, Nessa R. Foxe, Winston T. Wang, Aviram Nessim, Gillian Carling, Bangyan Liu et al. · 2025 · Molecular Neurodegeneration
  70. Tracking tau and cellular responses in human iPSC‐microglia: from uptake to seedable secretion, including in extracellular vesicles
    Maria Kreger Karabova, Anna del Ser‐Badia, Anne Hedegaard, Sam J. Washer, Zeynep Baykam, Darragh Patrick O'Brien, Iolanda Vendrell, Svenja Hester, Roman Fischer, Errin Johnson et al. · 2026 · Alzheimer s & Dementia
  71. The Adult Neurogenesis Theory of Alzheimer’s Disease
    Carlo Abbate · 2023 · Journal of Alzheimer s Disease
  72. Effects of anti‐tau immunotherapy on reactive microgliosis, cerebral endotheliopathy, and cognitive function in an experimental model of cerebral malaria
    Oscar Bate Akide Ndunge, Henry J. Shikani, Minxian Dai, Brandi D. Freeman, Mahalia S. Desruisseaux · 2023 · Journal of Neurochemistry
  73. Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer’s disease
    Miles R. Bryan, Xu Tian, Jui‐Heng Tseng, Baggio Evangelista, Joey V. Ragusa, Audra F. Bryan, Winifred Trotman, David John Irwin, Todd J. Cohen · 2024 · Acta Neuropathologica Communications
  74. Adverse effects of a SOD1-peptide immunotherapy on SOD1G93A mouse slow model of amyotrophic lateral sclerosis
    Javier Sábado, Anna Casanovas, Hess Michelini Rodrigo, Glòria Arqué, Josep Enric Esquerda · 2015 · Neuroscience
  75. Clearing truncated tau protein restores neuronal function and prevents microglia activation in tauopathy mice
    Alejandro Martín‐Ávila, Swananda Modak, Hameetha B. Rajamohamedsait, Andie Dodge, Dov B. Shamir, Senthilkumar Krishnaswamy, Leslie A. Sandusky‐Beltran, Marilyn Walker, Yan Lin, Erin E. Congdon et al. · 2025 · Cell Reports
  76. The engagement of microglia in tau-targeted immunotherapy in Alzheimer’s disease
    Denisa Palova, Natalia Turic Csokova, Karina Markova, Eva Kontseková, Branislav Kováčech, Monika Žilková · 2021 · General Physiology and Biophysics
  77. Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
    Donata De Marco, Renske L. R. E. Taggenbrock, Rosa Crespo, Wouter Koudstaal, Elizabeth A. Ramsburg, Adrian C. Apetri · 2018 · Journal of Visualized Experiments
  78. All-Trans Retinoic Acid-Induced Cell Surface Heat Shock Protein 90 Mediates Tau Protein Internalization and Degradation in Human Microglia
    Ngoc Lan Nguyen, Thi Xoan Hoang, Jae Young Kim · 2024 · Molecular Neurobiology
  79. Live Imaging of Pathological Tau Protein and Tau Antibodies in a Neuron-Like Cellular Model
    Dov B. Shamir, Yan Deng, Einar M. Sigurdsson · 2018 · Methods in molecular biology
  80. DAP12 deficiency alters microglia-oligodendrocyte communication and enhances resilience against tau toxicity
    Wenjie Luo, Hao Chen, Li Fan, Qi Guo, Man Ying Wong, Fangmin Yu, Nessa R. Foxe, Winston T. Wang, Aviram Nessim, Gillian Carling et al. · 2023 · Research Square
  81. Mechanistic Population Pharmacokinetic–Pharmacodynamic Model of the Tau‐Targeted Antibody Posdinemab in Healthy Participants and Participants with Alzheimer’s Disease
    Carlos Pérez‐Ruixo, Lingjue Li, Wendy R. Galpern, Juan José Pérez Ruixo · 2025 · Clinical Pharmacology & Therapeutics
  82. Microglia–astrocyte crosstalk as a key organizing principle of Alzheimer’s disease: from homeostatic cooperation to maladaptive signaling loops
    Mingqiang Gong, Jiao Xia Lan, Jifei Miao · 2026 · Frontiers in Aging Neuroscience
  83. Clinical immunology lessons from failed α-Synuclein and Tau immunotherapies: A roadmap for combination strategies in Alzheimer's disease
    Ahmed M Abdelaziz, Fatma S Eltyar · 2026 · Clinical Immunology
  84. Neuroglia targeting nano-therapeutic approaches to rescue aging and neurodegenerating brain
    Manju Sharma, Nidhi Aggarwal, Jibanananda Mishra, Jiban Jyoti Panda · 2024 · International Journal of Pharmaceutics
  85. Passive Immunotherapy for Tau Pathology
    Peter Davies · 2016 · Elsevier eBooks
  86. Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease
    Anil Gupta · 2021 · Elsevier eBooks
  87. Microglia become hypofunctional and release metalloproteases and tau seeds after phagocytosing live neurons with P301S tau aggregates
    Jack Brelstaff, Matthew Mason, Taxiarchis Katsinelos, William A. McEwan, Bernardino Francesco Ghetti, Aviva M. Tolkovsky, Maria Grazia Spillantini · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Recent updates on immunotherapy in neurodegenerative diseases
    Jotiram Salunkhe, Rajesh Ramesh Ugale · 2024 · Brain Research
  89. New Insights into Microglia as Therapeutic Targets in Alzheimer’s Disease
    Deepa S. Mandlik, Satish K. Mandlik, Heena Bholaram Choudhary · 2023 · Current Drug Therapy
  90. Pathophysiology and Management Approaches in Alzheimer’s Disease
    Shreshta Jain, Divya Goel, Sheikh Sana Nazir, Vaishali Yadav, Divya Vohora · 2023 · Springer eBooks
  91. Cholesterol and Dementia: A Possible Therapeutic Approach
    Jessica Sarahi Alavez-Rubio, Teresa Juárez‐Cedillo · 2022 · Springer eBooks
  92. Traumatic Brain Injury and Neurodegenerative Disease
    Dawn McGuire · 2018 · Wiley eBooks
  93. Concomitant AD and DLB pathologies shape subfield microglia responses in the hippocampus
    Sonja Fixemer, Corrado Ameli, Gaël Paul Hammer, Luis Salamanca, Oihane Uriarte Huarte, Chantal Schwartz, Jean‐Jacques Gérardy, Naguib Mechawar, Alexander Skupin, Michel Guy André Mittelbronn et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Faculty Opinions recommendation of Tau kinetics in neurons and the human central nervous system.
    Mark John Millan · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  95. Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease
    Chimal-Juárez, Enrique, Patel, Henika, Jury-Garfe, Nur, Dabin, Luke C., Vidal, Ruben, Kim, Jungsu, Lasagna-Reeves, Cristian A. · 2026 · bioRxiv
  96. Tau proteolysis mechanisms and relevance for tauopathies
    James P. Quinn · 2019 · Research Explorer (The University of Manchester)
  97. TREM2 Limits Progression of Deficits and Spreading of Tau Pathology in Mice
    Astrid Feiten, Carol G. Au, Annika van Hummel, Julia van der Hoven, Yuanyuan Deng, Magdalena Przybyla, Fiona Bright, Troy A. Butler, Fabien Delerue, Amer Toutonji et al. · 2021 · Research Square
  98. The Role of Microglial-Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) in Neuronal Homeostasis and Tau Pathogenesis
    Vaishnavi Jadhav · 2021 · IUScholarWorks (Indiana University)
  99. Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
    Donata De Marco, Renske L. R. E. Taggenbrock, Rosa Crespo, Wouter Koudstaal, Elizabeth A. Ramsburg, Adrian C. Apetri · 2018 · Journal of Visualized Experiments
  100. Neuroinflammation triggers microglial phagocytosis of synapses via induction of synaptic filopodia
    Carla Cangalaya, Susanne Wegmann, Wei‐Lun Sun, Lisa Diez, Anna Gottfried, Karin Richter, Stoyan Stoyanov, Janelle M.P. Pakan, Klaus‐Dieter Fischer, Alexander E. Dityatev · 2022 · Research Square